What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 3 minute read Pharma Industry News Biogen to acquire Nightstar Therapeutics in a deal worth $800m to target retinal diseases In a significant move within the biotech sector, Biogen, the US-based biotechnology giant, has announced its agreement to… bypharmanewsdailyMarch 31, 2019